Insulin, bovine Report issue

Animal product Approved FDA
AACT ChEMBL DrugBank Drugs@FDA PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

ins hypurin bov isop | insulin | insulin beef | insulin (beef) | insulin bovine | insulin purified beef | insulin susp isophane beef | insulin susp isophane purified beef | insulin zinc susp beef | insulin zinc susp extended beef | insulin zinc susp extended purified beef | insulin zinc susp extended recombinant human | insulin zinc susp prompt beef | insulin zinc susp purified beef | lente iletin ii | lente insulin | ormd 0801 | protaphane | regular iletin ii | semilente insulin

Organizations (17)

Research & Development (14)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (5)

Approved Indications (1)


 

Diabetes Mellitus, Type 2 (approved 1922)

Experimental Indications - Clinical Trial Phases 1-4 (5)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Hyperlipidemias (Phase 2/Phase 3)

Liver Transplantation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial Organizations: 14

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue